Meta Biomed Co., Ltd. (KOSDAQ:059210)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,935.00
+55.00 (1.42%)
At close: Jul 16, 2026
Market Cap106.92B -26.3%
Revenue (ttm)99.67B +0.4%
Net Income9.78B -56.4%
EPS358.29 -45.2%
Shares Out 27.17M
PE Ratio10.98
Forward PE5.84
Dividend105.00 (2.67%)
Ex-Dividend DateJun 29, 2026
Volume68,872
Open3,880.00
Previous Close3,880.00
Day's Range3,840.00 - 3,965.00
52-Week Range3,300.00 - 6,600.00
Beta0.55
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux... [Read more]

Industry Dental Equipment and Supplies
Founded 1990
Employees 314
Stock Exchange KOSDAQ
Ticker Symbol 059210
Full Company Profile

Financial Performance

In 2025, Meta Biomed's revenue was 102.95 billion, an increase of 9.48% compared to the previous year's 94.04 billion. Earnings were 10.99 billion, a decrease of -50.95%.

Financial Statements